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It is widely acknowledged that RNA stability plays critical roles in bacterial adaptation and survival in diﬀerent environments like
those encountered when bacteria infect a host. Bacterial ribonucleases acting alone or in concert with regulatory RNAs or RNA
binding proteins are the mediators of the regulatory outcome on RNA stability. We will give a current update of what is known
about ribonucleases in the model Gram-positive organism Bacillus subtilis and will describe their established roles in virulence in
severalGram-positivepathogenicbacteriathatareimposingmajorhealthconcernsworldwide.Implicationsonbacterialevolution
through stabilization/transfer of genetic material (phage or plasmid DNA) as a result of ribonucleases’ functions will be covered.
The role of ribonucleases in emergence of antibiotic resistance and new concepts in drug design will additionally be discussed.
1.Introduction
Bacterial pathogens predominantly respond to environmen-
tal changes, such as entry into a host, by adapting their
physiology through altered gene expression. The gene prod-
ucts that give a pathogen an enhanced chance of survival
within the host are termed virulence factors. Pathogens use
a variety of diﬀerent mechanisms to regulate virulence gene
expression. Besides transcriptional control, several post-
transcriptional mechanisms have been well documented in
the literature [1, 2]. In the recent years, messenger RNA
(mRNA) stability emerges as a major player controlling the
expression levels of proteins that allow pathogenic bacteria
to thrive within the host. The stability of mRNA is dictated
by the activity of ribonucleases (RNases) that act either alone
or in the presence of small regulatory RNAs (sRNAs) and/or
with ancillary proteins. The stability of mRNA also depends
on growth stage, environmental cues, or stresses (such as the
presence of nutrients, metabolites) as well as cell-density, a
phenomenon known as quorum sensing [3, 4].
A variety of posttranscriptional regulatory strategies in-
volve RNases. The cell can directly control global RNA
decay by adjusting the levels of RNases [4, 5]. Studies using
Escherichia coli and Bacillus subtilis have given a detailed
knowledge about the mechanisms of RNA decay and matu-
ration for Gram-negative and Gram-positive bacteria [6, 7].
For instance, posttranscriptional control mediated by sRNAs
and RNases is particularly important as it provides the cell
with a means to adapt rapidly to sudden environmental
changes and stresses. Moreover, it is energetically less costly
as it bypasses the need for new protein synthesis. Addition-
ally, fast removal of the sRNA regulator when the stress is
over allows the cell to recover and return to its previous
genetic program [1]. The advent of new technologies such
as deep-sequencing and tiling arrays revealed a plethora of
sRNAs and antisense RNAs (asRNAs) encoded in the bacte-
rial genomes [8–11]. Although their functions and the con-
ditions under which they are expressed are only now starting
to be understood, we expect a lot of exciting discoveries in
the ﬁeld of RNA regulation.
In this paper, we will primarily focus on RNase-mediated
regulation of virulence gene expression in medically relevant
Gram-positive bacteria. Diﬀerent mechanisms will be pre-
sented showing that RNases can either activate or repress
gene expression. The involvement of RNases in bacterial
antiviral defense, transfer of mobile genetic elements and2 International Journal of Microbiology
persistencewillbepresented.Wediscussthegenomiccontext
within which RNases are embedded and how the conserva-
tion of patterns amongst several genomes can give us insight
into their expression. Perspectives on the design of new
generation antibiotics targeting several components of the
RNA degrading machinery will be underscored.
2.The RNA DecayMachinery
Decades of research have resulted in the identiﬁcation/
characterization of several RNases within B. subtilis.A n
exhaustive overview of these is beyond the scope of this
paper and we refer readers to some high-quality review
articles that cover this topic [5, 7]. Instead, with an emphasis
on the most recent discoveries, we will present the works
done in B. subtilis for speciﬁc RNases where homologues
in pathogens have been associated with virulence. RNases
are broadly divided into two groups: (1) exoribonucleases,
which degrade RNA substrates from either the 5  or 3 end
and (2) endoribonucleases that cleave internally within an
RNA molecule. The orchestration of mRNA decay in Gram-
positive bacteria by the concerted action of several RNases is
illustrated schematically in Figure 1.
2.1. RNase Y. Recently, an essential gene within B. subtilis
(ymdA) was determined to be involved with RNA processing
andwasrenamedRNaseY[12,13].RNaseYcleavesunpaired
regions of RNA and subsequent work demonstrated that
RNase Y is the functional equivalent to RNase E in E. coli, the
majorsingle-strandspeciﬁcendoribonucleasewhichinitiates
RNA processing and degradation [14]. Interestingly, changes
in expression levels of RNase Y within B. subtilis resulted in
altered stability of polycistronic mRNAs required for bioﬁlm
formation [15], but this phenotype may be attributed to a
polar eﬀect on expression of the downstream gene, ymdB,
which has been shown to be required for bioﬁlm formation
[16]. RNase Y was reported to be involved in riboswitch
t u r n o v e r ,a sw e l la st oa ﬀe c tg l o b a lm R N Ad e c a y[ 12, 15].
Recent data from distant bacteria show that RNases such
as E. coli RNase E and B. subtilis RNase Y are not evenly
distributed in the cytoplasm but that a fraction is localized
at the membrane [17, 18]. Although it is not known whether
the localization is a regulated process, the transmembrane
domain of RNase Y is essential for the activity of the enzyme
in vivo [14]. Therefore, these data suggest that RNA turnover
is somehow compartmentalized in the cell and that the
spatial organization of RNases in bacteria is an additional
layer of regulation.
2.2. RNases J1 and J2. B. subtilis RNase J1/J2 have been the
subject of intensive research recently. RNases J1 and J2 were
ﬁrst identiﬁed and characterized in B. subtilis as the compo-
nent that endonucleolytically cleaved the thrS leader mRNA
[19].EarlierworkinB.subtilisdemonstratedthatonlyRNase
J1 is essential for growth [20]. Size exclusion chromatogra-
phy reveals that recombinant RNase J1 from B. subtilis elutes
as both a homodimer and a tetramer [21]. RNases J1/J2 are
bifunctional and possess both endoribonuclease and 5 –3 
exoribonuclease activities [19, 22]. Additionally, these two
proteins can form a heterodimeric complex that has unique
cleavage site speciﬁcities and eﬃciency [23].
The exoribonuclease activity of RNase J2 has been shown
to be signiﬁcantly less eﬃcient compared to RNase J1 [23].
The 5 –3  exonuclease activity, previously not identiﬁed in
bacteria, appears to be the major function in vivo [23]. It
has been demonstrated that RNase J1 is involved with global
RNA turnover and with processing of 16S and 23S rRNAs
[24, 25]. The 5  triphosphate of primary transcripts and/or
the presence of a hairpin structure at the 5  end protect RNA
from degradation by the exoribonuclease activity of RNase
J1 [22, 26]. RNases J1/J2 have been found associated with
the Gram-positive degradosome complex [13, 27] (discussed
below).
The ﬁrst structure solved for RNase J1 was from Thermus
thermophilus [26]. The protein consists of three domains, a
core β-lactamase domain, a β-CASP domain, that is speciﬁc
to members of the β-lactamase superfamily of enzymes act-
ing on nucleic acids, and a unique C-terminal domain, that
is joined by a ﬂexible linker to the β-lactamase domain. Two
catalytic zinc (Zn) ions were found in a cleft between the
β-lactamase and β-CASP domains. However, this structure,
bound to a UMP substrate, appeared to be in a closed
conformation that could not explain the 5  monophosphate
substrate preference nor did it reveal the mechanism for the
dual-enzyme activities [26]. The structure of a catalytically
inactive mutant form of RNase J1 associated with a 4 nt RNA
sequence has recently provided new insights for the mecha-
nismsofthedualenzymaticactivitiesandRNAbinding [28].
The binding of the RNA induces a change in the relative
position of the three domains with respect to each other as
well as speciﬁc alterations in conformation of the speciﬁc β-
CASP and β-lactamase domains. These movements result in
a widening of the narrow catalytic cleft between the domains
creating a channel that is wide enough for a single-stranded
RNA to enter. The cleaved nucleotide is discharged from the
other side through a negatively charged exit tunnel [28]. The
binding of RNA causes major rearrangements within the β-
CASP domain where speciﬁc loop regions are displaced by
up to 12 ˚ A to accommodate the substrate. The RNA binding
pocket consists of positively charged residues that extend
beyond the cleavage site, giving a rationale for the binding of
longer RNA transcripts and the endoribonucleolytic activity.
T h er e c e n t l ys o l v e ds t r u c t u r ea n dm o d e l i n go fB. subtilis
RNase J1 has revealed a similar pattern of conformational
changes upon substrate binding [21].
2.3. PNPase. In B. subtilis, the nonessential multifunctional
PNPase (77kDa) is the major exonucleolytic RNase, that
forms a trimer to catalyze the 3  to 5  phosphorolytic
degradation of RNA [29–31]. Additionally, under certain
conditions, PNPase is able to add nucleotides to the 3  end of
RNA [32]. The 3  binding and processivity of PNPase appear
to be blocked by strong hairpin secondary structures such
as Rho-independent terminators, which are often found at
the ends of B. subtilis transcripts and the processivity was
inhibited by the Not I sequence (GCGGCCGC) [33]. Thus,International Journal of Microbiology 3
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Figure 1: Diagram illustrating RNA decay by the RNases involved in virulence in Gram-positive bacteria. Removal of pyrophosphate
from the 5  end of mRNA by RppH is represented by the scissors. The degradation of RNA via the 3  end is mediated by the 3  to 5 
exoribonucleolyticactivityofPNPase(inyellow).RNasesJ1andJ2(ingreen)cleaveRNAendoribonucleolyticallyandexoribonucleolytically
in the 5  to 3  direction. RNase Y (in pink) and the dsRNA-speciﬁc RNase III (in blue) cleave RNA endoribonucleolytically.
it is believed that PNPase plays the secondary step in RNA
decay and that the degradation of nucleotides only occurs
after the 3  end becomes exposed due to an endonucleolytic
cleavage by another RNase (RNase III, RNase Y, or RNase
J1/J2) [7].
It is interesting to mention some of the remarkable
new functions discovered involving this versatile protein.
Recently, PNPase was found to copurify with B. subtilis
RecN and this complex was able to degrade single-stranded
DNA (ssDNA) in vitro [34]. The exonucleolytic activity of
PNPase on ssDNA was characterized and a functional role
for PNPase in homologous DNA recombination in B. subtilis
wasidentiﬁed[34].Extendingfromthisworkthesamegroup
was able to show that B. subtilis PNPase catalyzes template-
independent polymerization of dNDPs onto 3  ends of
ssDNA [35]. This work has led to the establishment of a
molecular model for the role of PNPase in DNA repair [35].
2.4. RNase III. Bacterial RNase III belongs to the Class I
RNase III family of enzymes, while Classes II and III include
the eukaryotic Drosha and Dicer, respectively, which are
involved in biogenesis of siRNA/miRNA in higher organisms
(reviewed in [3, 36, 37]). The bacterial RNase III is the
smallestofRNaseIIIfamilymembersconsistingofacatalytic
and a dsRNA binding domain [38]. It functions as a homod-
imer with dimerization occurring through the ribonuclease
domains [39]. Recently, a fourth class of RNase III enzymes
was found with the discovery of the endoribonuclease Mini
III, which is involved with the ﬁnal steps of maturation
of 23S rRNA. This enzyme lacks three out of four dsRNA
binding domains and consists of only the catalytic domain
[40]. The structures of bacterial as well as eukaryotic RNase
III enzymes have helped in understanding their functions
(reviewed in [36]).
RNase III is a Mg2+-dependent double-strand-speciﬁc
endoribonuclease capable of cleaving dsRNA. It recognizes
a variety of structures such as imperfect duplexes, helices
interrupted by bulged residues, kissing loops, and stacked
helices [41–44]. Cleavage by RNase III produces the charac-
teristic type of dsRNA with a 5  phosphate and a 3  hydroxyl
group and a 2nt 3 -overhang (reviewed in [5–7]). RNase
III is involved in the maturation of large ribosomal RNAs
in E. coli and B. subtilis [45]a sw e l la si nt h er e g u l a t i o n
of single and polycistronic mRNAs [5–7, 46]. Moreover, it
is involved in the maturation of other housekeeping RNAs
such as the small cytoplasmic RNA (scRNA) precursor in
B. subtilis [47–49]. No consensus sequence motif has been
deﬁned for this enzyme but “antideterminants” have been
proposed to prevent the recognition of RNA molecules by E.
coli RNase III [50].
2.5. RNase P. RNase P is a ribonucleoprotein particle that
contains at least one protein subunit and a single-ribozyme
subunit [51]. In B. subtilis, RNase P has been shown to cleave
precursor tRNAs and tmRNA forming the mature 5  end
and to cleave the adenine riboswitch which stabilizes the4 International Journal of Microbiology
downstream mRNA transcript [52, 53]. The catalytic site is
located in the RNA subunit [54]. Crystal structures of RNase
P either alone [55] or bound to tRNA [56] reveal that the
RNA-RNA recognition occurs through shape complemen-
tarity and conserved intermolecular contacts. The active site
structure and the conserved RNase P-tRNA contacts suggest
a universal mechanism for catalysis. Since biochemical and
structural mechanisms for recognition and cleavage of RNA
substrates by RNase P have been characterized in-depth by
several groups, we refer the readers to an excellent recent
review for a comprehensive summary of this work [57].
2.6. RppH. In E. coli, RNA pyrophosphohydrolase (RppH)
removes a pyrophosphate from the 5  end of RNA, con-
verting the triphosphate into a monophosphate, a reaction
that occurs before RNA degradation by RNase E [58]. The
ﬁnding that a 5  triphosphate on RNA is a poor substrate
for RNase J1/2 in B. subtilis [19] inspired Richards et al. [59]
to search for the functional RppH homologues in B. subtilis.
Bioinformatic searches identiﬁed six putative homologues
with canonical Nudix hydrolase motifs. To identify the
functional RppH, these proteins were expressed and assayed
for the deprotection event in vitro. They identiﬁed an RppH-
dependent B. subtilis transcript by constructing a rrpH
strain and screening for mRNAs with altered half-lives
[59]. Detailed study of the processing of a polycistronic
mRNA reveals that RppH converts the 5  triphosphate to
a monophosphate mRNA prior to degradation by RNase
J1. Even though the RppH has not yet been implicated
in virulence, this discovery reveals an additional stage in
the elegant orchestration of RNA decay. This mechanism
is reminiscent of the decapping step that triggers mRNA
degradation in eukaryotes [60].
2.7. The Existence of a Degradosome in Gram-Positive Bacte-
ria. The degradosome has been ﬁrst discovered and charac-
terized in E. coli [61–63]. A degradosome complex within
Gram-positive bacteria has remained elusive until recently
[13]. While screening for in vivo interaction partners
of glycolytic enzymes within B. subtilis, several proteins
known to be involved with RNA processing and degra-
dation were identiﬁed [13]. The primary protein-protein
interactions were further evaluated using the bacterial two-
hybrid approach. The Gram-positive degradosome consists
of three RNases (RNase J1/J2, RNase Y), polynucleotide
phosphorylase (PnpA) and two glycolytic enzymes (phos-
phofructokinase and enolase) [13]. Further characterization
identiﬁed a DEAD box RNA helicase (CshA) that interacts
with RNase Y and PnpA [27]. This helicase was predicted
to be localized at the membrane since the protein carries a
N-terminal transmembrane domain similar to the sequence
present on RNase Y [27]. Recently, the degradosome from
S. aureus has been characterized and evaluated using the
bacterial two-hybrid approach [64]. Although this work
conﬁrmed the conservation of the B. subtilis multienzymatic
complex, diﬀerent partner interactions were described and
additionally,theassociationoftheproteinsubunitofribonu-
clease P (RnpA) with CshA was demonstrated [64].
2.8. Genomic Context of RNases. The importance of genomic
organization and operon structure for gene expression has
been well documented [65]. Often genes with similar func-
tion or associated to the same biosynthetic pathway tend
to be found within the same operon or in close proximity
on the chromosome. Combining genomic information from
severalpublicdatabases(NCBI,genolist,andBiocyc.org),we
analyzedtheconservationofgeneticorganizationacrossfour
families of pathogenic Gram-positive bacteria additionally
including B. subtilis. Using the multigenome alignment tool
(http://www.biocyc.org/), the genomic context was aligned
for several Gram-positive organisms (see Figures 1–8 in Sup-
plementary material available online at doi: 10.1155/2012/
592196). Some of the most noteworthy features are high-
lighted below.
Several of the genes (pnpA, rnjB, rny) for the proteins
involved in the degradosome are located in a relative close
proximity to each other on the chromosome and genetic
arrangements appear to have evolved in Gram-positive
species (Figure 3). However, a loose conservation of pnpA-
rnjB-rny gene cluster is observed among the genomes.
Interestingly,thepresenceof rpsOupstreamofpnpAisfound
inallgenomesandinE.coliaswell,suggestingthatpnpAand
rpsO are ancient genes of a common origin. In B. subtilis,
pnpA is part of a polycistronic operon located 8kb upstream
of rnjB, and the rnjB operon is sandwiched between two
chromosomal regions that contain several sporulation genes.
In S. aureus, pnpA and rnjB are located directly next to
each other (Figure 3). In Clostridia species, no RNase J2
homologue was found, but a large genomic rearrangement
has brought pnpA relatively close to rny.I nListeria species,
av e r yd i ﬀerent genomic context is observed, where large
genomic insertions separate the genes of this cluster. The
proximity of pnpA-rnjB-rny locus within several Gram-
positive organisms may have functional consequences. For
instance, located within the same locus are certain genes
that have been identiﬁed to cross-regulate expression and
activity.TheenzymaticactivityofPNPaseonsingle-stranded
DNA is in part modulated by RecA, a gene located upstream
of rny [35]. Decay of the highly conserved rpsO mRNA is
initiated by RNase Y followed by PNPase [66]. Recently, in
Streptomyces coelicolor, it has been shown that transcripts
originating at the rpsO promoter read-through into pnpA
and become processed by RNase III [67].
The clustering of RNase genes, along with several
genes for sporulation, cell wall peptidoglycan biosynthesis,
motility, and cell division are also noteworthy. In E. faecalis,
cotranscribed with rnjB a r et w og e n e si n v o l v e dw i t hc e l l
wall biosynthesis and rnjB has been shown to regulate
pili formation at the posttranscriptional level [68]. In B.
subtilis,R N a s eY( rny/ymdA) is the ﬁrst gene of a bicistronic
operon including ymdB which was recently shown to play
a critical role in the bistable expression of genes involved
in ﬂagella and bioﬁlm formation [16]. Moreover, the genes
located upstream of rny, pgsA (cell wall biosynthesis),
cinA (competence-damage inducible regulator), and recA
(member of SOS regulon) are relatively conserved among
Gram-positive bacteria. The gene encoding CshA, the RNA
helicase of the degradosome in B. subtilis [27], is also part ofInternational Journal of Microbiology 5
an operon including two genes encoding proteins involved
in peptidoglycan biosynthesis. The genomic context of this
operon is conserved in other species (see Supplementary
Figure 8). RNase III (rnc) is transcribed as the ﬁrst of a three-
gene operon in B. subtilis, also encoding the essential smc
(chromosome condensation and segregation ATPase) and
ftsY (signal recognition particle) [69]. This organization is
also highly conserved in all Gram-positive species (see Sup-
plementary Figure 2).
Transcriptomic array data for S. aureus [74, 75]r e v e a l
that all RNases are expressed in vegetative growth. At the
transition to stationary phase, the levels either (i) drop
dramatically and remain low thereafter for RNase J2, RNase
Y, and RNase P or (ii) reduce slightly only to catch back later
into stationary phase for RNase J1, PNPase, and RNase III.
The reduced transcript levels of several S. aureus RNases
in stationary phase [74, 75] appear to correlate with the
demand for peptidoglycan/ribosome biosynthesis.
3. RibonucleasesActing in Virulence
3.1. Global Roles of RNases in Virulence. The role of several
RNases in virulence has been recently studied in two major
pathogenic bacteria, Streptococcus pyogenes and Staphylococ-
cus aureus. S. pyogenes (group A Streptococci,G A S )a n dS.
aureus cause mild to systemic and life threatening diseases.
The emergence of methicillin resistant S. aureus strains
acquired both in hospitals and, in the community, has
resulted in more deaths annually than HIV in the United
States in recent years [76, 77].
GAS transcripts have been recently classiﬁed into two
Classes, I and II, depending on their stability during sta-
tionary phase of growth [78]. Class I transcripts appear
very labile during stationary phase, while Class II transcripts
encoding several virulence factors such as sagA (streptolysin
S), sda (DNase), and arc (arginine deiminase) have pro-
longed half-lives. It has been shown that the 3 –5  exonu-
cleolytic activity of PNPase is responsible for degrading
substrates of class II after an elongated lag phase where
mRNAs are stable [79]. The initial endoribonucleolytic
cleavage of Classes I and II transcripts is mediated by RNases
J1andJ2,whichareessentialinGAS[78,80].Itwasproposed
that Class I transcripts are better substrates for RNases J1
and J2 and only after their depletion, degradation of Class
II transcripts is initiated. The amounts of RNases J1, J2, and
PNPase as well as putative signals they respond to, might be
critical for such growth phase-dependent regulation.
The roles of ribonucleases in virulence gene expression
are summarized in Table 1. RNase Y, encoded by cvfA in
Streptococcus and Staphylococcus, has been shown to aﬀect
virulence in both pathogenic bacteria in silkworm and
murine models [81–83]. In S. pyogenes,acvfA deletion af-
fected expression of several virulence factors [82]. Moreover,
microarrayanalysisrevealeddiﬀerentialexpressionof29%of
genes indicative of the importance of RNase Y in the initia-
tion of mRNA decay [82]. These data suggested that RNase Y
mediated downregulation of metabolism and upregulation
of certain virulence factors facilitates the acquisition of
cellular components from the host. The eﬀect of RNase Y
on virulence gene expression occurred mainly in stationary
phase [82] in agreement with data showing that virulence
factor expression in S. pyogenes is strictly dependent on
growth phase [84]. RNase Y-mediated regulation was shown
tobedependentonthenutritionalstatusofthecellsimplying
thattheenzymeisinvolvedissensingthenutrientavailability
(directly or indirectly) [82]. However, its deletion did not
aﬀect the ppGpp levels, therefore the observed eﬀects were
not linked to stringent response [82]. S. pyogenes RNase
Y interacts with the glycolytic enzyme enolase [82]w h i c h
might provide a link between nutritional status and RNase
Y-mediated gene expression. RNase Y has been reported to
aﬀect production of virulence factors in S. aureus either
through expression of the accessory gene regulatory locus,
agr orindependently[83].Biochemicalanalysesrevealedthat
the predicted phosphohydrolase domain (HD domain) of
RNaseYpossessesaphosphodiesteraseactivityagainst2 ,3  -
cyclic nucleotide and this activity is required for virulence
[83]. RNase Y was predicted to contain a transmembrane
domain in S. pyogenes and S. aureus [82, 83], similar to the
B. subtilis enzyme [17].
Studies have indicated that the capacity of S. aureus to
diﬀerentially express subsets of virulence factors according
to stress and growth phase is largely attributed to mRNA
stability [4]. In particular, it was shown that mRNA stabiliza-
tion occurs in stationary phase as well as under cold-, heat-,
acid-,andalkaline-shockandthestringentresponse[85,86].
The authors showed that PNPase aﬀected bulk mRNA decay
and was shown to be essential for cold-growth [4] as is the
caseforE.coli,Salmonellaenteric,andseveralYersiniaspecies
(reviewedin[87]).Inaddition,RNasePwasalsodescribedas
a major RNase involved in bulk mRNA degradation that has
direct consequences on the expression of virulence factors
at the stationary phase of growth [75]. Interestingly, rnpA-
depleted cells exhibited attenuated virulence in a mouse
infection model [75].
3.2. RNases and Mechanisms of Regulation of Speciﬁc Genes in
Pathogenic Bacteria
3.2.1.sRNAandRNasesActivatingGeneExpression. Theacti-
vation of an S. pyogenes mRNA encoding a virulence factor
(ska,streptokinase)dependsonthepresenceofasRNA,FasX
[70]. FasX binds to ska mRNA 30nts upstream of the AUG
and forms a 7 nts-long helix. This double-stranded structure
leads to an increased stability of the mRNA (Figure 2(a)).
Notably, a C-rich sequence motif present on FasX is em-
ployed for the interaction, similarly to what has been de-
scribed for S. aureus RNAIII and other sRNAs [71, 88].
Deletion of either RNase Y or PNPase did not result in
stabilization of ska mRNA indicating that FasX-dependent
stabilization is due to a limited access of RNases at the 5 -
end [70]. Whether the 5 -3  exoribonucleolytic property of
RNases J1 and J2 is responsible for ska mRNA degradation,
remains to be tested.
Within Clostridium perfringens, the VirR/VirS two-com-
ponent system regulates several virulence genes including
transcription of the 386 nts sRNA, VR-RNA [89]. Recent6 International Journal of Microbiology
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Figure 2: Diagram illustrating diﬀerent mechanisms of posttranscriptional regulation. (a) Stabilization of S. pyogenes ska mRNA. Transcript
levels of ska are regulated by RNase-mediated decay. Under stress conditions, the FasX sRNA is expressed and binds to the 5  leader region
of ska mRNA inhibiting RNase degradation [70]. (b) S. aureus RNAIII/RNase III repression of translation. The quorum-sensing regulatory
RNAIII uses a regulatory hairpin to bind to spa mRNA (or SA1000) target sequence. The initial loop-loop interaction is converted to a
duplex sequestering the Shine-Dalgarno sequence (SD). Access of the ribosome is blocked and translation is repressed. RNase III is recruited
to the hybrid region and to an additional hairpin present in spa and cleaves the transcript making the regulatory event irreversible [71, 72].
(c) Repression of B. subtilis TxpA toxin synthesis. The asRNA Rat is transcribed convergently and is fully complementary to the txpA mRNA.
Binding of Rat asRNA to txpA transcript induces rapid degradation of the mRNA [73]. The RNase performing the initial cleavage might be
RNase III although the nature of the enzyme and the structure of the hybrid are not yet determined.
work by Obana et al. [90] has shed light onto the VR-RNA-
dependent regulation of the toxin collagenase (colA). Base
pairing of VR-RNA with the 5 UTR of colA mRNA induces
cleavage by an unknown RNase immediately downstream
of the colA-VR-RNA duplex. This processing in turn leads
to the formation of a shorter hairpin and increased mRNA
stability in vivo. Mutational analysis of the RBS indicates
that ribosome binding to the processed mRNA additionally
stabilizes the colA mRNA [90].
Hence, the secondary structure of mRNA has an impor-
tant role in controlling transcript stability as highlighted by
the two examples for ska and colA mRNAs [70, 90]. Interest-
ingly we have shown that in S. aureus, RNase III mediates
transcript stabilization of cspA mRNA, encoding a cold-
shockprotein,throughprocessingofalonghairpinstructure
in the 5 UTR. This processing leads to the formation of a
short but stable hairpin that enhances the stability of the
mRNA and its translation (Lioliou et al., submitted).
Enterococcus faecalis is an opportunistic Gram-positive
responsible for many nosocomial infections [91]. Recently,
Gao et al. [68] showed that the E. faecalis rnjB, encoding
RNase J2, is involved in the regulation of pilus gene expres-
sion and bioﬁlm formation. Pili expression is important
for pathogenicity of many Gram-positive organisms [92].
Inactivation of rnjB results in destabilization of ebp operon
transcript encoding the pilus proteins [68]. The mechanism
of action by which RNase J2 stabilizes the mRNA and
whether this regulation takes place in other Gram-positive
bacteria producing pili remains to be shown.
3.2.2. sRNA and RNases Repressing Gene Expression. The
eﬀect of RNase III in virulence in S. aureus has been well
documented. Speciﬁcally, in stationary phase, RNase III
acts together with the agr encoded regulatory RNAIII [93]
to repress the expression of several adhesin factors and the
repressor of toxins, Rot [44, 71, 72]. RNAIII is a multifunc-
tional RNA that encodes a virulence factor, hemolysin
delta. Through its 3  UTR, RNAIII interacts with mRNAs
either by forming imperfect duplexes or by promoting
the formation of loop-loop interactions. In cases where
translational repression occurs, the Shine-Dalgarno is
sequestered and ribosome binding is prevented. RNAIII-
mRNA complexes in turn constitute targets for RNase III
cleavage to render regulation irreversible (Figure 2(b)).
Translational repression of Rot indirectly results in the
activation of toxins and in the repression of adherence
factors. As more functions of regulatory RNAs are unveiled
[8, 88, 94–96], it is predicted that other sRNAs, such as
the group I toxin-antitoxin systems, might act coordinately
with RNase III to regulate gene expression. In a recent
report, it was shown that a Δrnc strain was attenuated in a
murine infection model, and that RNase III is involved in
the regulation of extracellular protein secretion, such as the
extracellularﬁbrinogenbindingproteinEfbinS.aureus[97].International Journal of Microbiology 9
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Figure 3: Alignment of the genomic context for three components of the RNA degradosome. Homologues of PNPase, RNase J2, and
RNase Y were aligned from the diﬀerent Gram-positive organisms, Bacillus subtilis 168, Bacillus anthracis A0248, Staphylococcus aureus
N315, Clostridium diﬃcile 630, and Listeria monocytogenes HCC23. Alignments were made using the multigenome alignment tool on
http://www.biocyc.org/. Red lines indicate directly adjacent regions of the chromosome and the diagonal lines indicate a chromosomal
gap. Genes that are conserved in bacteria are shown with the same color.
This was achieved through regulation of the levels of secY2
mRNA encoding a protein of the accessory secretory system.
In Gram-negative bacteria, Hfq has been shown to be
a critical component of sRNA-mediated regulation [98].
Evidence of a similar role for Hfq in Gram-positive bac-
teria has remained elusive until recently [99]. Work by
Nielsen et al. [100] showed that within Listeria monocyto-
genes, translational regulation of lmo0850 mRNA mediated
by the binding of LhrA sRNA is dependent on Hfq. The
speciﬁc RNases involved in the degradation of the lmo0850
transcript still remain to be determined. Additionally, a
lhrA deletion within L. monocytogenes altered the expression
levels of approximately 300 genes, including chiA, a known
virulence factor that encodes a chitinase [101].
3.2.3. RNase and Defense Mechanism: CRISPR. Recently,
the role of RNase III in bacterial immunity against phages
and plasmids has been demonstrated [102]. CRISPR/Cas
(clustered, regularly interspaced short palindromic repeats/
CRISP-associatedproteins)systemsmediatebacterialimmu-
nity against foreign invading DNA, such as plasmid and
phages. The CRISPR genetic loci encode for spacer-repeat
sequences as well as their associated Cas endoribonucleases.
The repeat sequence is usually identical and can be found
between 2–249 times within a locus. The spacer sequences
are unique and originate from phage or plasmid sequences
that have been integrated in the genome and which sub-
sequently confer immunity against the speciﬁc phage or
against plasmid conjugation [103–107]. The CRISPR loci
are transcribed as a long pre-crRNA, which is then matured
into small RNAs (crRNA) consisting of a single spacer-repeat
unit, which eﬀectively attacks foreign DNA. Processing of
pre-crRNA into crRNAs is usually performed by the Cas
endoribonucleases. However, some Cas homologues are
absent from certain subtypes of CRISPR systems as in
S. pyogenes, which lacks three Cas proteins, Cse3 (CasE),10 International Journal of Microbiology
Cas6, and Csy4. In these cases, the host-encoded RNase III
mediatesmaturationofthepre-crRNAactinginconcertwith
a trans-encoded RNA (trans-activating CRISPR RNA, tracr-
RNA) and the endoribonuclease Csn1 [102]. Particularly,
it has been reported that tracrRNA interacts with almost
perfect complementarity with the repeat units in the pre-
crRNA. In a ﬁrst processing event, RNase III cleaves speciﬁ-
callythe duplexes and subsequently,a second cleavageoccurs
in the spacer sequence. The exact mechanism underlying the
second processing event and whether it is carried out by
Csn1 remains to be elucidated. Csn1 also aids the interaction
of the two RNAs and possibly stabilizes the tracrRNA.
This type of regulation was found conserved in other
bacteria such as Listeria innocua, Neisseria meningitides,
Streptococcus mutans, and Streptococcus thermophilus.B a s e d
onexaminationofseveralbacterialgenomes,itwassuggested
that tracrRNA possibly co-evolved with the repeat sequences
of crRNA [102].
3.2.4. Unusual RNases: Riboswitches with Catalytic Activities.
Riboswitches are cis-acting regulatory RNA sequences that
control expression of downstream genes by binding metabo-
lites that induce structural changes to the transcript [108].
An interesting study recently highlighted the regulatory
importance of cyclic-di-GMP [109]. In this study, a new
class of c-di-GMP riboswitch was identiﬁed that is linked in
tandem to an allosteric self-splicing ribozyme upstream of
a putative virulence gene within the genome of Clostridium
diﬃcile. Binding of c-di-GMP to this RNA structural motif
induces folding changes at the splice site causing a diﬀerent
splicing pattern. The binding of c-di-GMP results in the
inclusion of a perfect RBS directly upstream of a nonconven-
tional UUG translational start codon. Without the second
messenger signal, c-di-GMP, the ﬁnal spliced mRNA lacks
the RBS and is not translated [110]. This work illustrates a
new level of posttranscriptional complexity within bacteria.
The discovery of the mechanism for transcript destabi-
lization induced by the glmS ribozyme has demonstrated
how the cell can sense nutritional status and modulate gene
expressionaccordinglyusingcatalyticRNAcleavagefollowed
by RNase-mediated decay [111]. In B. subtilis, glucosamine-
6-phosphate binds to the glmS ribozyme stimulating site-
speciﬁc RNA self-cleavage in vivo. This cleavage results in
transcripts that contain a 2 -3  cyclic phosphate at the 3 
end and a hydroxyl group at the 5  end. After cleavage, the
downstream transcript is rapidly degraded. It was shown
that targeting of glmS RNA for degradation was due to
the 5  hydroxyl end which was a substrate for the 5 –
3  exoribonuclease activity of RNase J1 [111]. This work
demonstrates that metabolite-sensing ribozymes enable the
cell an eﬃcient means to respond to their environment.
3.2.5. Toxin-Antitoxin Systems and Stress Response. Toxin-
antitoxin (TA) systems are continuously being discovered
across bacterial species. Their involvement in phage resis-
tance, plasmid maintenance, stress responses, and bacterial
persistence is well documented (for reviews, see [112–118]).
These systems are classiﬁed into three main types. In the
ﬁrst one, the antitoxin is a noncoding RNA (ncRNA), which
is antisense to the mRNA encoding the toxin. For type II,
both toxin and antitoxin are proteins. Type III (ToxIN) was
recently discovered and employs an antitoxic sRNA, which
bindsandinhibitsaproteintoxin.FortypeIIandIIIsystems,
the toxin and the antitoxin are cotranscribed as part of
an operon, whereas for type I systems the two genes are
encoded on the opposite strands overlapping in their 5 -o r
3 -ends. In all cases the antitoxin, RNA or protein, is labile
and subject to degradation, while the toxin is stable. Upon
conditions that favor elimination of the antitoxin, the TA
complexisdisrupted,andthetoxinisreleased(ortranslated)
to exert its toxic eﬀect. Type I toxins usually consist of small
hydrophobic peptides, the translation of which is turned oﬀ
by antisense RNAs (asRNAs) [116]. In the case of E. coli
hok/Sok and tisAB/IstR systems, RNase III is the key enzyme
which degrades the mRNA-asRNA complex [118]. Toxins of
type II act usually as endoribonucleases (MazF and RelE)
or inhibit DNA gyrase (CcdB) [112–114]. The E. coli MazF
is an endoribonuclease cleaving mRNAs at a deﬁned ACA
consensus sequence independently of the ribosome, while
RelE is a ribosome-dependent endoribonuclease that cleaves
mRNAspositionedattheribosomalA-site(reviewedin[112,
114]). The unique type III toxin, ToxN, was demonstrated
to have endoribonuclease activity in vitro and was capable
of cleaving its inhibitory antitoxic sRNA [119, 120]. These
data suggest that ToxN possibly acts as an RNase to inhibit
translation and slow down bacterial growth. The mRNA
targets of ToxN remain to be discovered.
T h eo n l yt y p eI IT As y s t e mi d e n t i ﬁ e di nB. subtilis so far
is ndoAI/ndoA where ndoA encodes the toxin (EndoA, MazF
homologue), which cleaves at unpaired UACAU sequences,
and ndoAI encodes the antitoxin [121, 122]. Depending of
the nature of the stress, the TA module in B. subtilis can be
protective or lethal [123]. The authors hypothesized that this
behavior would allow the cell a way to determine if the stress
w a sm i l de n o u g ht ob er e p a i r e do rs os e v e r ea st oa c t i v a t et h e
cell death pathway [123] .I n t e r e s t i n g l y ,at y p eIT As y s t e m
encoded in the chromosome of B. subtilis was identiﬁed
[73]. It consists of the TxpA toxin and its asRNA, RatA. The
two RNAs are transcribed convergently overlapping at their
3  ends. Pairing between txpA-RatA leads to degradation of
the mRNA by an unknown RNase (Figure 2(c)). Given its
speciﬁcity for dsRNA, RNase III could be a good candidate
to mediate the degradation. As the number of asRNAs found
in bacterial genomes constantly increases [8–11], RNase
III might prove to be an important player in this type of
regulation.
The PemIK TA module from B. anthracis has recently
been characterized [124]. The PemK was shown to be an
endoribonuclease toxin that shares 96% similarity to the
EndoA (MazF homologue) toxin from B. subtilis.B i o -
chemical characterization of the TA module conﬁrmed that
PemI inhibits PemK-mediated endoribonuclease activity.
The catalytic residues in PemK were deﬁned in vitro,a n d
surprisingly, the catalytic mutants retained the capacity to
bind PemI eﬃciently [124]. The PemIK interaction was
characterized in vitro giving clues to the conformational
changes that take place following complex formation.International Journal of Microbiology 11
Synthetic peptides were designed to disrupt the PemI-PemK
interaction and to inhibit the endoribonuclease activity of
PemK, demonstrating that TA modules can be potential
antimicrobial targets [124].
The identiﬁcation of MazEF and to a smaller extent axe-
txe, relBE, and ε-ζ homologues in plasmids of vancomycin
resistance enterococci (VRE) isolated from patients [125]
demonstrates their clinical importance. The authors showed
that the MazEF system was transcribed and endowed ente-
rococci with plasmid stability. Moreover, the mazEF genes
were located on the same plasmid with the vancomycin
resistance gene cluster, vanA. Recently, the axe-txe system
was identiﬁed in a plasmid from Enterococcus faecium,w h i c h
also encoded multiple drug resistances. The system was
expressed in clinical isolates and Txe was shown to have
endoribonucleolytic activity in vivo [126]. The presence of
these systems in enterococcal plasmids might imply a role
in the transfer of antibiotic resistance genes to other species
such as MRSA [127] linking TA systems to development of
virulence.
MazEF was also identiﬁed in S. aureus and the unpaired
UACAU recognition sequence for endoribonucleolytic cleav-
age was established [128, 129]. Induction of MazEF leads to
destabilization of sraP mRNA which contains the consensus
cleavage motif. The occurrence of the consensus sequence
within coding sequences of other virulence factors was also
demonstrated [129]. The induction of the MazEF had an
eﬀect on the expression of spa and hla mRNAs [130]. As
mazEF and sigB are transcriptionally linked, sigB expression
is partially dependent on factors aﬀecting transcription of
mazEF such as heat-shock and antibiotic stresses [131].
SigB was also shown to downregulate expression of mazEF,
therefore creating a feedback inhibitory loop that possibly
aﬀects its own expression [131]. These ﬁndings have sig-
niﬁcant implications in mediation of stress responses and
virulence as SigB is a major regulator of these biological
processes in S. aureus [132]. Recently, the expression of a
chromosomally encoded MazEF system in clinical isolates of
MRSA strains was reported [133] .T h e r e f o r e ,t h i sT Am o d u l e
is an important player in regulation of pathogenicity and
might constitute a novel target for antibiotics.
Interestingly, it was recently shown that E. coli MazF
cleaves preferentially ACA sequences in mRNAs located close
by to the AUG codon thus generating leaderless mRNAs
[134]. In addition, the enzyme also cleaves 16S rRNA within
the 30S subunit and removes its last 43 nucleotides including
the anti-Shine and Dalgarno sequence. This in turn creates
a subpopulation of ribosomes that are able to translate the
leaderless mRNAs [134]. Whether the formation of such
specialized ribosomes produced under stress conditions can
be generalized to all bacteria remains to be addressed.
Mycobacterium tuberculosis is a major worldwide health
problem and in 2009 approximately 1.7 million people were
estimated to have died from tuberculosis (WHO, Global
tuberculosis control report 2011, WHO/HTM/TB/2011.16).
Bioinformatic analyses revealed that M. tuberculosis encodes
88 putative TA systems, 30 of which were shown to be
functional [135]. Remarkably, most of the TA systems were
conserved within the M. tuberculosis complex (MTBC) while
they were absent from closely related species. This implies
that they were acquired after the speciation event and that
they probably play a signiﬁcant role in pathogenicity. The
VapBC is the most abundant TA module in M. tuberculosis
represented by 47 members. Subsets of VapBC modules were
showntobetoxicwhenexpressedandconverselythistoxicity
was counteracted by coexpression of the cognate VapB
antitoxin[135,136].VapCfunctionsasanRNaseinvitroand
this may accountforthe inhibition of translation observed in
vivo which profoundly aﬀects gene expression in response to
diﬀerent environments and stresses [135, 136]. Certain sets
of TA systems were found upregulated under hypoxia and
during infection of macrophages [135]. Previously, it was
shown that the recognition sequences of MazF-mtb were less
frequently present in proteins associated with pathogenicity
(reviewed in [113]). Hence, certain TA modules can direct
degradation of speciﬁc mRNAs in response to stress rather
than inhibit bulk translation.
Interestingly, Winther and Gerdes [137] have shown that
entericVapCencodesatRNasethatcleavesinitiatortRNAfMet
between the anticodon stem and loop. Cellular depletion of
tRNAfMet had a bacteriostatic eﬀect on cultures and produc-
tion of VapB allowed cells to resume growth. The depletion
of tRNAfMet by VapC not only inhibited cell growth but
was additionally found to activate initiation of translation at
correctly positioned elongator codons. The authors further
speculated that this mechanism has the potential to translate
reading frames that were normally silent. This work in
enteric bacteria has signiﬁcant implications for virulence in
Gram-positive organisms, particularly M. tuberculosis where
VapBC modules are highly represented [135, 136]. The
oxidative burst within macrophages generates superoxide
anion (O2
−) and singlet oxygen, which can be lethal to cells
[138]. A mechanism to globally reduce translation, such as
cleavage of tRNAfMet, would reduce the occurrence of toxic
events and enhance survivability of the organism.
Bacterial persistence is a phenotype where part of the
cell population enters a dormant nongrowing state which
in turn confers resistance to antibiotics and other stresses
[139]. The involvement of TA systems in development of
persistenceinE.coliwasrecentlyreported[140].Theauthors
showed that overexpression of the toxin led to the persister
phenotype and that successive deletion of all TA systems
in E. coli resulted in a dramatic decrease in formation of
persisters [140]. Consistent with involvement of TA systems
in the persistence phenotype, the transcriptome of persister
M. tuberculosis revealed overexpression of TA systems [141].
The importance of the CRISPR systems in antiphage
resistance was discussed earlier. Abortive infection (Abi)
is mediated by the type III ToxIN systems and constitutes
another mechanism by which bacteria defend against phages
[142]. During Abi, a phage-infected bacterium altruistically
commits suicide to prevent the spread of phage within the
population. ToxIN systems were identiﬁed in the Gram-
negative phytopathogen Erwinia carotovora but homologues
are found in the genomes of several Gram-positive and
Gram-negative pathogenic bacteria [120]. The hok/Sok (type
I), MazEF (type II) systems have also been shown to confer12 International Journal of Microbiology
phage resistance to their hosts (reviewed in [112, 118]).
This type of antiviral immune system could be critical for
limiting horizontal transfer of phage encoded virulence
factors between pathogenic species.
4. Regulation of RNase Activityand
RNA Stability:EmergingIssues
4.1. RNases and sRNA-Dependent Regulation. RNases often
act in concert with sRNAs and/or RNA binding proteins.
Interaction with a sRNA can lead to occlusion of the
ribosome binding to repress translation. Often an RNase
is recruited to the site of interaction to degrade the mRNA
making the regulation irreversible. It has also been proposed
that in the absence of ribosome binding, the mRNA becomes
more exposed to the action of RNases so that repression of
translation can lead to rapid degradation [3, 5]. Therefore,
sRNAs are key players in ﬁne-tuning mRNA levels. Most of
ourknowledgeonsRNAstabilitycomesfromGram-negative
bacteria. In those cases examined, RNase III, PNPase, and
RNase E are involved in the degradation of the sRNA, which
can be coupled or uncoupled to that of the mRNA target
[143–146]. Hfq is also an important player which protects
the sRNAs against degradation [98]. Unexpectedly, sRNAs
were recently shown to be destabilized in E. coli pnpA mutant
cells in exponential phase of growth. It was proposed that
PNPase protects sRNAs from degradation mediated by
RNase E [144]. While S. aureus RNase III has been shown
to initiate the decay of mRNAs repressed by the quorum
sensing dependent RNAIII [87], little is known on the roles
of RNases associated with the sRNA-dependent regulation
in Gram-positive bacteria.
In the cases described so far where regulation of mRNA
stability occurs through the combined action of a sRNA
and a ribonuclease, the initial cleavage site is located within
the mRNA-sRNA duplex as it is the case for RNase III
[99] or proximal to the base-pairing region as exempliﬁed
f o rR N a s eE[ 1, 6]. A novel mode of action for E. coli
RNase E was recently reported where the enzyme acts at
a distance cleaving further into the coding sequence [147].
RNase E was found tethered to the RBS of sodB mRNA
through association with Hfq and the sRNA RyhB which in
turn occluded ribosome loading onto the RBS. When the
mRNAwas stripped oftranslating ribosomes, RNase E cleav-
age sites present within the coding sequence were exposed to
the endonucleolytic activity of RNase E. Whether a similar
mechanism exists in Gram-positive bacteria, remains to be
elucidated.
Hfq, although a major player in sRNA-mediated degra-
dation in Gram-negative bacteria [98] ,d o e sn o ts e e mt o
have such an important role in RNA decay in Gram-
positive bacteria with one exception reported so far (see
earlier). Other RNA binding proteins may carry out the
role of Hfq. Interestingly, a conserved protein was found in
Sinorhizobium meliloti, SMc01113/YbeY, which shares struc-
tural similarities with the MID domain of the Argonaute
(AGO) proteins. Deletion of this protein induces pleiotropic
eﬀects as found for Hfq. Moreover, the protein regulates
the accumulation of sRNAs and mRNAs similarly to Hfq
[148]. This protein is conserved in Gram-positive bacteria
although its function has not yet been studied in these
organisms. In B. subtilis, three small basic proteins were
proposedtoactasRNAchaperonesactinginconcertwiththe
sRNA FsrA, to promote degradation of transcripts encoding
iron-using proteins under conditions of iron deprivation
[149].
Hence, these examples illustrate the important role of
RNases in mRNA turnover and gene regulation and show
that repression of translation mediated by sRNA (also
by translational repressor proteins) is often subsequently
followed by mRNA degradation. All these regulatory events
involve the catalytic activity of the enzymes. However, one
cannot exclude that RNases might also regulate gene expres-
sion solely through their RNA binding activity. Notably, the
dsRNA binding activity of RNase III has been reported to
promote translation of lambda phage cIII RNA [150].
4.2. Modiﬁcation of the Degradosome. The activity of RNases
or other enzymes of the degradosome can be modulated.
The ﬁrst evidence of a modiﬁed degradosome came during
a screen for suppressors of a cold-sensitive phenotype in
a csdA mutant [151]. It was demonstrated that the RNA
helicase, csdA, becomes incorporated in the RNA degrado-
some complex in E. coli after cold shock [151] and it can
functionally replace RhlB, the typical RNA helicase within
the degradosome. It was proposed that the cold shock-
induced CsdA associates with the degradosome to facilitate
the unwinding of structured RNAs at cold temperatures.
Furthermore, recent evidence revealed the association of
the degradosome with components of central metabolism
suggesting that these modiﬁed complexes may be part of
a feedback network that allows the cell to coordinate RNA
decay with metabolic conditions. In Caulobacter crescentus,
the Krebs cycle enzyme aconitase was found associated with
thedegradosomeasopposedtotheglycolyticenzymeenolase
that is found in E. coli [152]. Binding of aconitase to the
complex occurred through interaction with RNase E and
levels of RNase E varied during the cell cycle. The connection
between RNA decay and central metabolism was further
illustrated by the fact that citrate, a metabolite of the Krebs
cycle, has an inhibitory eﬀect on the activity of PNPase in E.
coli [153]. It was recently pinpointed that an oxygen sensing
system is able to adjust the level of c-di-GMP available to
PNPase within a large ribonucleoprotein complex in E. coli
and that this enhances PNPase activity [154]. Within this
complex, PNPase, enolase, RNase E, RNA terminator protein
Rho, several chaperone proteins (DnaJ, DnaK, GroEL), and
oxygen-sensing proteins (DosC and DosP) were identiﬁed in
addition to an RNA moiety [154]. Altogether these diﬀerent
studies have identiﬁed variations to the degradosome com-
plex that confer to the cell the capacity to sense and adapt
to environmental changes. It is expected that future work
characterizing modiﬁcations of the degradosome complex
and their impact on RNA decay will uncover connections
between RNA regulation and global metabolism.International Journal of Microbiology 13
Moreover, several examples have been highlighted where
the activity of RNases can be cross-regulated. For instance, E.
coli PNPase synthesis is autoregulated at the posttranscrip-
tional level by an RNase III-dependent mechanism [155].
In fact, many of the RNases also appear to be regulated
by a feedback mechanism and due to the fact that they
are involved in rRNA processing, their expression is thus
coordinated with ribosome synthesis [156–158]. Moreover,
a protein regulator has been reported for E. coli RNase III
[159]. One can envision sRNAs possibly having a role in
modulating ribonuclease activity. As underscored above, the
genomic context of the RNases might oﬀer valuable cues
towards understanding regulation of their expression. Stage
ofgrowthanddiﬀerentstressesemergeascommonthemesin
regulation of RNases activity [4, 78]. Surely our appreciation
of regulation of RNase activity is far from being complete.
5. Conclusions andPerspectives
This paper highlights the importance of RNases in gene
expression in several Gram-positive pathogenic bacteria.
Furthermore, we have illustrated by several examples the
roles of speciﬁc RNases in the regulation of the expression
of mRNA targets involved in virulence. However, the full
repertoire of targets for RNases, and the roles of accessory
proteins (RNA helicases, RNA-binding proteins) in gene reg-
ulation still need to be assessed, especially in Gram-positive
bacteria. Without doubt our knowledge will greatly advance
from current methodologies such as deep sequencing and
tiling arrays where the full RNome of a bacterium can be
evaluated in wild-type and mutant backgrounds. Moreover,
high-throughput sequencing combined with crosslinking
immunoprecipitation (HITS-CLIP) has proven valuable
for identifying RNA-protein interactions [160, 161]. This
method could also lead to identiﬁcation of the set of target
RNAs of an RNase. These new possibilities are expected to
oﬀer valuable insights into the function of these enzymes.
The emergence of antibiotic resistances amongst patho-
genic bacteria urgently necessitates the discovery of novel
drugs. Several possibilities of targeting components of the
RNA decay machinery in the design of novel drugs have been
reported. Recently, an inhibitory compound of RnpA was
identiﬁed that proved to be eﬀective against several strains of
MRSA, bioﬁlm associated S. aureus and against other Gram-
positive pathogens [75]. Despite the fact that the identiﬁed
molecule exhibited cytotoxicity against a human cell line and
cannot be further exploited, it nevertheless sets the foun-
dation for novel antimicrobial strategies targeting the RNA
degrading machinery. Riboswitches have also been inves-
tigated as possible drug targets. Eﬀorts have been focused
on designing ligands nonmetabolizable by the cell that can
speciﬁcally target riboswitches and repress growth [162,
163]. TA systems have been suggested as good candidates for
novel antibacterial strategies. Two modes of action have been
envisioned for newly designed drugs aiming at activation
of the toxin. The ﬁrst approach involves turning down
production of the antitoxin either at the transcriptional or
the translational level whereas the second one aims at the
disruption of the toxin-antitoxin interaction. In both cases,
the result is degradation of the labile antitoxin and release of
the toxin which ultimately results in self-inﬂicted cell death
[164]. The emergence of antibiotic resistances often relies on
the presence of resistance genes residing on mobile genetic
elements like plasmids [125]w h i c hc a nb et r a n s f e r r e dt o
diﬀerent species [127]. Since TA modules are responsible
for stabilization of these elements, a strategy for targeting
TA systems seems to hold promise for the design of novel
antibiotics.
6. Note Added inthe Proof
Ar e c e n ts t u d yb yL a s ae ta l .[ 165] revealed an RNA quality
control function of S. aureus RNase III. The enzyme elim-
inates antisense RNA production by speciﬁc processing of
sense-antisense complexes.
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